ISSN 2515-8260
 

Review Article 
EJMCM. 2017; 3(5): 233-251


VEGF mimic peptides: Potential applications in central nervous system therapeutics

Luca Domenico D'Andrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi.

Abstract
VEGF is expressed in central nervous system and its expression increases in hypoxia and in inflammatory brain disorders. A wealth of data suggests that VEGF may exert neuroprotective activities and promote neuroregeneration in disease status. Moreover, the risk of developing certain neurological disorders may be dependent on dysfunction in the VEGF system. Therefore, a strong rationale does exist to suggest that VEGF-based therapeutics could be implemented in conditions such as stroke or amyotrophic lateral sclerosis and experimental data supporting this hypothesis have been obtained. However, the unfavorable pharmacokinetic profile of this growth factor, and concerns on its safety have limited the development of VEGF as a therapeutic tool for neurological disorders. In this review, we discuss why a new class of VEGF-mimic peptides holds promises to become a safer, cheaper and more easily manageable tool for central nervous system therapeutics.

Focal Points

Bench: The analysis of the effects of small peptides reproducing one or more regions of VEGF may help understanding basic issues on the structure-activity relationship of this growth factor.


Bedside: Small VEGF-mimic peptides could have better pharmacokinetic and/or toxicological properties than VEGF and be, therefore, potentially suitable for use in human diseases.


Community: VEGF-mimic peptides-based therapeutics could help reducing the burden of severe neurodegenerative disorders that cannot be efficiently treated with currently available drugs.

Key words: VEGFStrokeAlzheimer diseaseParkinson's diseaseAmyotrophic Lateral SclerosisNeurodegenerationEpilepsyQK peptideIntranasal administration


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Luca Domenico D'Andrea
Articles by Lucia De Rosa
Articles by Chiara Vigliotti
Articles by Mauro Cataldi
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. VEGF mimic peptides: Potential applications in central nervous system therapeutics. EJMCM. 2017; 3(5): 233-251.


Web Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. VEGF mimic peptides: Potential applications in central nervous system therapeutics. http://www.ejmcm.com/?mno=116125 [Access: June 18, 2020].


AMA (American Medical Association) Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. VEGF mimic peptides: Potential applications in central nervous system therapeutics. EJMCM. 2017; 3(5): 233-251.



Vancouver/ICMJE Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. VEGF mimic peptides: Potential applications in central nervous system therapeutics. EJMCM. (2017), [cited June 18, 2020]; 3(5): 233-251.



Harvard Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi (2017) VEGF mimic peptides: Potential applications in central nervous system therapeutics. EJMCM, 3 (5), 233-251.



Turabian Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. 2017. VEGF mimic peptides: Potential applications in central nervous system therapeutics. European Journal of Molecular & Clinical Medicine, 3 (5), 233-251.



Chicago Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. "VEGF mimic peptides: Potential applications in central nervous system therapeutics." European Journal of Molecular & Clinical Medicine 3 (2017), 233-251.



MLA (The Modern Language Association) Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi. "VEGF mimic peptides: Potential applications in central nervous system therapeutics." European Journal of Molecular & Clinical Medicine 3.5 (2017), 233-251. Print.



APA (American Psychological Association) Style

Luca Domenico DAndrea, Lucia De Rosa, Chiara Vigliotti, Mauro Cataldi (2017) VEGF mimic peptides: Potential applications in central nervous system therapeutics. European Journal of Molecular & Clinical Medicine, 3 (5), 233-251.